Labcorp to offer first FDA-cleared blood test for initial Alzheimer’s disease assessment

Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer ...
Fierce Biotech

Labcorp signs on to carry Roche's newly FDA-cleared Alzheimer's blood test

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...
Zacks Investment Research on MSN

Labcorp Gears Up to Report Q3 Earnings: What's in Store for the Stock?

Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2025 results on Oct. 28, before the market opens.
Business Insider

Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease

Test is available through physicians for use with patients being evaluated for possible Alzheimer's disease or other causes of cognitive impairment Labcorp is the first company to deliver a ...
Morningstar

Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search

BURLINGTON, N.C., July 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its-kind ...
Hosted on MSN

Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up

Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...